Alerts will be sent to your verified email
Verify EmailTTKHLTCARE
|
TTK Healthcare
|
3B Blackbio Dx
|
Nureca
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Domestic Sales Growth - YoY
|
22.38 % | n/a | n/a |
|
R&D as a % of Total Sales
|
0.02 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
19.91 % | 30.57 % | 4.74 % |
|
5yr average Equity Multiplier
|
1.3 | 1.21 | 1.09 |
|
5yr Average Asset Turnover Ratio
|
0.72 | 0.5 | 0.66 |
|
5yr Avg Net Profit Margin
|
24.27 % | 44.97 % | 2.08 % |
|
Price to Book
|
1.25 | 3.33 | 1.44 |
|
P/E
|
21.24 | 18.41 | 124.75 |
|
5yr Avg Cash Conversion Cycle
|
-3.67 Days | 128.05 Days | 90.04 Days |
|
Inventory Days
|
43.41 Days | 30.75 Days | 109.16 Days |
|
Days Receivable
|
41.32 Days | 137.66 Days | 12.7 Days |
|
Days Payable
|
110.17 Days | 46.71 Days | 25.4 Days |
|
5yr Average Interest Coverage Ratio
|
23.15 | 440.19 | 12.64 |
|
5yr Avg ROCE
|
8.03 % | 37.21 % | 5.66 % |
|
5yr Avg Operating Profit Margin
|
4.06 % | 51.13 % | -1.98 % |
|
5 yr average Debt to Equity
|
0.03 | 0.01 | 0.0 |
|
5yr CAGR Net Profit
|
9.57 % | -15.98 % | -45.92 % |
|
5yr Average Return on Assets
|
15.8 % | 23.36 % | 2.88 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
74.56 % | 40.95 % | 68.09 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 2.52 % | 5.11 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-2.98 % | 0.0 | 0.0 |
|
TTK Healthcare
|
3B Blackbio Dx
|
Nureca
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|